Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Policy
Musculoskeletal/Multiple Sclerosis (MS) (1)
Government (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Regulatory Review & Approval